519 related articles for article (PubMed ID: 9105050)
1. Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells.
Mariani SM; Matiba B; Armandola EA; Krammer PH
J Cell Biol; 1997 Apr; 137(1):221-9. PubMed ID: 9105050
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage.
Mariani SM; Krammer PH
Eur J Immunol; 1998 Mar; 28(3):973-82. PubMed ID: 9541592
[TBL] [Abstract][Full Text] [Related]
3. Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease.
Cryns VL; Bergeron L; Zhu H; Li H; Yuan J
J Biol Chem; 1996 Dec; 271(49):31277-82. PubMed ID: 8940132
[TBL] [Abstract][Full Text] [Related]
4. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways.
Dubrez L; Savoy I; Hamman A; Solary E
EMBO J; 1996 Oct; 15(20):5504-12. PubMed ID: 8896444
[TBL] [Abstract][Full Text] [Related]
5. TRAIL/Apo-2-ligand-induced apoptosis in human T cells.
Jeremias I; Herr I; Boehler T; Debatin KM
Eur J Immunol; 1998 Jan; 28(1):143-52. PubMed ID: 9485194
[TBL] [Abstract][Full Text] [Related]
6. Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells.
Chlichlia K; Peter ME; Rocha M; Scaffidi C; Bucur M; Krammer PH; Schirrmacher V; Umansky V
Blood; 1998 Jun; 91(11):4311-20. PubMed ID: 9596680
[TBL] [Abstract][Full Text] [Related]
7. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR
Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844
[TBL] [Abstract][Full Text] [Related]
8. Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8.
Schempp CM; Simon-Haarhaus B; Termeer CC; Simon JC
FEBS Lett; 2001 Mar; 493(1):26-30. PubMed ID: 11277999
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 activated NK cells do not use the CD95L- and TRAIL-pathways in the rapid induction of apoptosis of rat colon carcinoma CC531s cells.
Velthuis JH; de Bont HJ; Medema JP; Kuppen PJ; Mulder GJ; Nagelkerke JF
Immunobiology; 2003; 207(2):115-27. PubMed ID: 12675269
[TBL] [Abstract][Full Text] [Related]
10. CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells.
Gamen S; Marzo I; Anel A; Piñeiro A; Naval J
FEBS Lett; 1996 Jul; 390(2):232-7. PubMed ID: 8706867
[TBL] [Abstract][Full Text] [Related]
11. E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation.
Shao R; Lee DF; Wen Y; Ding Y; Xia W; Ping B; Yagita H; Spohn B; Hung MC
Mol Cancer Res; 2005 Apr; 3(4):219-26. PubMed ID: 15831675
[TBL] [Abstract][Full Text] [Related]
12. Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling.
Los M; Mozoluk M; Ferrari D; Stepczynska A; Stroh C; Renz A; Herceg Z; Wang ZQ; Schulze-Osthoff K
Mol Biol Cell; 2002 Mar; 13(3):978-88. PubMed ID: 11907276
[TBL] [Abstract][Full Text] [Related]
13. Caspase-dependent ceramide production in Fas- and HLA class I-mediated peripheral T cell apoptosis.
Genestier L; Prigent AF; Paillot R; Quemeneur L; Durand I; Banchereau J; Revillard JP; Bonnefoy-Bérard N
J Biol Chem; 1998 Feb; 273(9):5060-6. PubMed ID: 9478956
[TBL] [Abstract][Full Text] [Related]
14. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.
Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S
Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934
[TBL] [Abstract][Full Text] [Related]
15. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.
Hermisson M; Wagenknecht B; Wolburg H; Glaser T; Dichgans J; Weller M
Oncogene; 2000 May; 19(19):2338-45. PubMed ID: 10822385
[TBL] [Abstract][Full Text] [Related]
16. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
Ahmad M; Shi Y
Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
[TBL] [Abstract][Full Text] [Related]
17. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases.
Deshmukh M; Vasilakos J; Deckwerth TL; Lampe PA; Shivers BD; Johnson EM
J Cell Biol; 1996 Dec; 135(5):1341-54. PubMed ID: 8947555
[TBL] [Abstract][Full Text] [Related]
18. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases.
Juo P; Kuo CJ; Reynolds SE; Konz RF; Raingeaud J; Davis RJ; Biemann HP; Blenis J
Mol Cell Biol; 1997 Jan; 17(1):24-35. PubMed ID: 8972182
[TBL] [Abstract][Full Text] [Related]
19. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis.
Vanags DM; Pörn-Ares MI; Coppola S; Burgess DH; Orrenius S
J Biol Chem; 1996 Dec; 271(49):31075-85. PubMed ID: 8940103
[TBL] [Abstract][Full Text] [Related]
20. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
Kim JH; Ajaz M; Lokshin A; Lee YJ
Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
